Patents by Inventor Deepak Phadke

Deepak Phadke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20240016791
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Application
    Filed: September 26, 2023
    Publication date: January 18, 2024
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20230382883
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 30, 2023
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Liquid Tasimelteon Formulations and Methods of Use Thereof
    Publication number: 20230372285
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 23, 2023
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 11760740
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: January 3, 2023
    Date of Patent: September 19, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Liquid tasimelteon formulations and methods of use thereof
    Patent number: 11759446
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: September 19, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20230150964
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: January 3, 2023
    Publication date: May 18, 2023
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 11566011
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: January 31, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Ophthalmic Pharmaceutical Compositions
    Publication number: 20230026577
    Abstract: The present invention provides ophthalmic pharmaceutical compositions of the compound of Formula (I).
    Type: Application
    Filed: December 4, 2020
    Publication date: January 26, 2023
    Applicant: Vanda Pharmaceuticals Inc.
    Inventors: Udaya KOTREKA, Deepak PHADKE
  • MELATONIN AGONIST TREATMENT
    Publication number: 20230021493
    Abstract: Melatonin Agonist, MA-1, is administered at effective doses.
    Type: Application
    Filed: October 14, 2022
    Publication date: January 26, 2023
    Inventors: Gunther P. Birznieks, Deepak Phadke, Mihael H. Polymeropoulos
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20220073482
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 11203581
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: December 21, 2021
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Liquid tasimelteon formulations and methods of use thereof
    Patent number: 11202770
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: December 21, 2021
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Liquid Tasimelteon Formulations and Methods of Use Thereof
    Publication number: 20210212980
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Application
    Filed: March 29, 2021
    Publication date: July 15, 2021
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Liquid Tasimelteon Formulations and Methods of Use Thereof
    Publication number: 20210177799
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Application
    Filed: December 11, 2020
    Publication date: June 17, 2021
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20210015809
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 21, 2021
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20210017143
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 21, 2021
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Iloperidone metabolite for use in the treatment of psychiatric disorders
    Patent number: 10874659
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 29, 2020
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • MELATONIN AGONIST TREATMENT
    Publication number: 20200397741
    Abstract: Melatonin Agonist, MA-1, is administered at effective doses.
    Type: Application
    Filed: September 1, 2020
    Publication date: December 24, 2020
    Inventors: Gunther P. Birznieks, Deepak Phadke, Mihael H. Polymeropoulos
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 10829465
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: November 10, 2020
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20200190048
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: February 25, 2020
    Publication date: June 18, 2020
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada